跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VALTAXIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VALTAXIN
Authorized
STANDARD
VALTAXIN
ENDO PHARMACEUTICALS SOLUTIONS INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6f0e7b96deb98665
Company
ENDO PHARMACEUTICALS SOLUTIONS INC
Type
Standard
Approval Details
Approval Id
6f0e7b96deb98665
Drug Approval Canada Name
VALTAXIN
Product Name
VALTAXIN
Status
Cancelled Post Market
Status Date
2017-08-01
Original Market Date
2001-04-23
Din
02242466
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravesical
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01DB09 VALRUBICIN
Atc Name
l 01 db 09
Aig Number
0141241001
Company Name
ENDO PHARMACEUTICALS SOLUTIONS INC
Company Address
1400 Atwater Drive, Malvern, Pennsylvania, United States, 19355
Company Detail Path
/organization/endo-pharmaceuticals-solutions-inc
Company Information
Pharmaceutical Company Name
ENDO PHARMACEUTICALS SOLUTIONS INC
Country Name
United States
Province Name
North Carolina
City Name
charlotte,north carolina,country_us
Address
3241 Woodpark Blvd
Active Ingredients
VALRUBICIN
40 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6f0e7b96deb98665
Type
Standard
Back to Health Canada Approvals